Difference between revisions of "Carcinosarcoma"

From Libre Pathology
Jump to navigation Jump to search
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Carcinosarcoma''' is a tumour with a malignant epithelial component ([[carcinoma]]) and a malignant mesenchymal component ([[sarcoma]]), based on histomorphology.
[[Image:Carcinosarcoma - high mag.jpg|thumb|right|Micrograph showing a carcinosarcoma. [[H&E stain]].]]
'''Carcinosarcoma''' is a tumour with a malignant epithelial component ([[carcinoma]]) and a malignant mesenchymal component ([[sarcoma]]), based on the histomorphology.


They can arise in a number of sites:
They can arise in a number of sites:
Line 6: Line 7:
*Fallopian tube carcinosarcoma.
*Fallopian tube carcinosarcoma.


==Relation to carcinoma, metaplastic carcinoma and sarcomatoid carcinoma==
==Relation of carcinosarcoma to metaplastic carcinoma and sarcomatoid carcinoma==
''Carcinosarcoma'' implies that the tumour arose from mesenchymal cells and epithelial cells simultaneously.
''Carcinosarcoma'' implies that the tumour arose from mesenchymal cells and epithelial cells simultaneously.


This is in contradistinction to (1) ''[[sarcomatoid carcinoma]]s'' which arise from epithelial cells and then transform to become sarcoma-like, and (2) ''[[metaplastic carcinoma]]s'' which arise from epithelial cells that have undergone a (morphologic) transformation (metaplasia).  
This is in contradistinction to:
# [[Sarcomatoid carcinoma]] - implies the tumour arose from epithelial cells only and is sarcoma-like (morphologically), and  
# [[Metaplastic carcinoma]] - implies the tumour arose from epithelial cells that had undergone a (morphologic) transformation (metaplasia).  


Uterine carcinosarcomas are generally considered [[metaplastic carcinoma]]s;<ref name=pmid25805398>{{Cite journal  | last1 = Cantrell | first1 = LA. | last2 = Blank | first2 = SV. | last3 = Duska | first3 = LR. | title = Uterine carcinosarcoma: A review of the literature. | journal = Gynecol Oncol | volume = 137 | issue = 3 | pages = 581-588 | month = Jun | year = 2015 | doi = 10.1016/j.ygyno.2015.03.041 | PMID = 25805398 }}</ref><ref name=pmid25468677>{{Cite journal  | last1 = Artioli | first1 = G. | last2 = Wabersich | first2 = J. | last3 = Ludwig | first3 = K. | last4 = Gardiman | first4 = MP. | last5 = Borgato | first5 = L. | last6 = Garbin | first6 = F. | title = Rare uterine cancer: carcinosarcomas. Review from histology to treatment. | journal = Crit Rev Oncol Hematol | volume = 94 | issue = 1 | pages = 98-104 | month = Apr | year = 2015 | doi = 10.1016/j.critrevonc.2014.10.013 | PMID = 25468677 }}</ref> they putatively arise from epithelial cells (only).
Uterine carcinosarcomas are generally considered [[metaplastic carcinoma]]s.<ref name=pmid25805398>{{Cite journal  | last1 = Cantrell | first1 = LA. | last2 = Blank | first2 = SV. | last3 = Duska | first3 = LR. | title = Uterine carcinosarcoma: A review of the literature. | journal = Gynecol Oncol | volume = 137 | issue = 3 | pages = 581-588 | month = Jun | year = 2015 | doi = 10.1016/j.ygyno.2015.03.041 | PMID = 25805398 }}</ref><ref name=pmid25468677>{{Cite journal  | last1 = Artioli | first1 = G. | last2 = Wabersich | first2 = J. | last3 = Ludwig | first3 = K. | last4 = Gardiman | first4 = MP. | last5 = Borgato | first5 = L. | last6 = Garbin | first6 = F. | title = Rare uterine cancer: carcinosarcomas. Review from histology to treatment. | journal = Crit Rev Oncol Hematol | volume = 94 | issue = 1 | pages = 98-104 | month = Apr | year = 2015 | doi = 10.1016/j.critrevonc.2014.10.013 | PMID = 25468677 }}</ref> They typically metastasize as [[carcinoma]]s,<ref name=pmid21309261>{{Cite journal  | last1 = Lopez-Garcia | first1 = MA. | last2 = Palacios | first2 = J. | title = Pathologic and molecular features of uterine carcinosarcomas. | journal = Semin Diagn Pathol | volume = 27 | issue = 4 | pages = 274-86 | month = Nov | year = 2010 | doi =  | PMID = 21309261 }}</ref> and putatively arise from epithelial cells (only).
 
The term ''carcinosarcoma'' is from the morphologic era of pathology;{{fact}} it precedes the modern battery of molecular tests and [[immunohistochemistry]].


==See also==
==See also==
Line 17: Line 22:
*[[Sarcomatoid carcinoma]].
*[[Sarcomatoid carcinoma]].
*[[Metaplastic carcinoma]].
*[[Metaplastic carcinoma]].
==References==
{{Reflist|2}}


{{disambiguation}}
{{disambiguation}}


[[Category:Gynecologic pathology]]
[[Category:Gynecologic pathology]]

Latest revision as of 05:42, 5 August 2015

Micrograph showing a carcinosarcoma. H&E stain.

Carcinosarcoma is a tumour with a malignant epithelial component (carcinoma) and a malignant mesenchymal component (sarcoma), based on the histomorphology.

They can arise in a number of sites:

Relation of carcinosarcoma to metaplastic carcinoma and sarcomatoid carcinoma

Carcinosarcoma implies that the tumour arose from mesenchymal cells and epithelial cells simultaneously.

This is in contradistinction to:

  1. Sarcomatoid carcinoma - implies the tumour arose from epithelial cells only and is sarcoma-like (morphologically), and
  2. Metaplastic carcinoma - implies the tumour arose from epithelial cells that had undergone a (morphologic) transformation (metaplasia).

Uterine carcinosarcomas are generally considered metaplastic carcinomas.[1][2] They typically metastasize as carcinomas,[3] and putatively arise from epithelial cells (only).

The term carcinosarcoma is from the morphologic era of pathology;[citation needed] it precedes the modern battery of molecular tests and immunohistochemistry.

See also

References

  1. Cantrell, LA.; Blank, SV.; Duska, LR. (Jun 2015). "Uterine carcinosarcoma: A review of the literature.". Gynecol Oncol 137 (3): 581-588. doi:10.1016/j.ygyno.2015.03.041. PMID 25805398.
  2. Artioli, G.; Wabersich, J.; Ludwig, K.; Gardiman, MP.; Borgato, L.; Garbin, F. (Apr 2015). "Rare uterine cancer: carcinosarcomas. Review from histology to treatment.". Crit Rev Oncol Hematol 94 (1): 98-104. doi:10.1016/j.critrevonc.2014.10.013. PMID 25468677.
  3. Lopez-Garcia, MA.; Palacios, J. (Nov 2010). "Pathologic and molecular features of uterine carcinosarcomas.". Semin Diagn Pathol 27 (4): 274-86. PMID 21309261.